Condition
Malignant Pleural Mesothelioma
Estimated Enrollment: 80
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: EF-23
Study First Received: March 19, 2015
Last Updated: March 28, 2017
Estimated Primary Completion Date: February 2018
Primary Outcome Measures:
Overall Survival|Progression Free Survival|Response Rate|Toxicity
Sponsors and Collaborators:
NovoCure Ltd.
Website Link: https://ClinicalTrials.gov/show/NCT02397928
